Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial-Reference-Cited by-同舟云学术

Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial

Published:2020-02 Issue:2 Volume:106 Page:349-357
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Tang Chad,Lee Won-Chul,Reuben Alexandre,Chang Lianpeng,Tran Hai,Little Latasha,Gumbs Curtis,Wargo Jennifer,Futreal Andrew,Liao Zhongxing,Xia Xuefeng,Yi Xin,Swisher Steven G.,Heymach John V.,Gomez Daniel,Zhang Jianjun

Funder

NCI

University of Texas MD Anderson Cancer Center

Lung Cancer Moonshot Initiative

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol,2016

3. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study;Gomez;J Clin Oncol,2019